scholarly article | Q13442814 |
P2093 | author name string | Charles H V Hoyle | |
Assumpta Peral | |||
Teresa Peláez | |||
Jesus Pintor | |||
P2860 | cites work | Effect of melatonin on intraocular pressure | Q68503508 |
Diurnal rhythms of immunoreactive melatonin in the aqueous humor and serum of male pigmented rabbits | Q68608116 | ||
Localization of 2-[125I]iodomelatonin binding sites in mammalian retina | Q70147223 | ||
Effects of brimonidine on aqueous humor dynamics in human eyes | Q71559414 | ||
Melatonin acts on the nucleus accumbens to increase acetylcholine release and modify the motor activity pattern of rats | Q73342037 | ||
The analgesic effects of peripheral and central administration of melatonin in rats | Q74254230 | ||
8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action | Q78088255 | ||
Characterization of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organs | Q28138056 | ||
Actions of melatonin in the reduction of oxidative stress. A review | Q34074485 | ||
Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors | Q35026489 | ||
Localization and function of dopamine in the adult vertebrate retina | Q35222963 | ||
Mammalian pineal melatonin: a clock for all seasons | Q38709987 | ||
Melatonin receptors: are there multiple subtypes? | Q40532109 | ||
Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma N1E-115 cells | Q41755819 | ||
The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye. | Q42488482 | ||
Identification of the melatonin-binding site MT3 as the quinone reductase 2. | Q42630663 | ||
Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits | Q43566827 | ||
Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 . | Q43593899 | ||
Melatonin receptor mRNA and protein expression in Xenopus laevis nonpigmented ciliary epithelial cells | Q43826185 | ||
Flesinoxan, a 5-HT1A receptor agonist/alpha 1-adrenoceptor antagonist, lowers intraocular pressure in NZW rabbits | Q43882842 | ||
Involvement of nitric oxide in the ocular hypotensive action of nipradilol | Q43929182 | ||
Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors | Q48162316 | ||
The chick retinal melatonin receptor revisited: localization and modulation of agonist binding with guanine nucleotides | Q48888829 | ||
The effects of melatonin on vasopressin secretion in vivo: interactions with acetylcholine and prostaglandins. | Q51552400 | ||
Melatonin agonists induce phosphoinositide hydrolysis in Xenopus laevis melanophores. | Q54565531 | ||
The ciliary body--the third organ found to synthesize indoleamines in humans | Q67540977 | ||
Aqueous humor cyclic AMP and circadian elevation of intraocular pressure in rabbits | Q68276769 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 831-836 | |
P577 | publication date | 2003-03-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor | |
P478 | volume | 138 |
Q98577688 | Changes in melatonin receptor expression in a murine model of glaucoma |
Q38949654 | Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability |
Q38584194 | Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions |
Q52739208 | Docking studies for melatonin receptors. |
Q53628648 | Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice. |
Q37847182 | Emerging drugs for ocular hypertension |
Q38229317 | Expression and putative functions of melatonin receptors in malignant cells and tissues |
Q36282807 | Functional MT1 and MT2 melatonin receptors in mammals |
Q93551696 | G Protein-Coupled Receptors |
Q54337814 | Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT. |
Q93498531 | Melatonin |
Q64979686 | Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle. |
Q34636280 | Melatonin inhibits tachykinin NK2 receptor‐triggered 5‐HT release from guinea pig isolated colonic mucosa |
Q41768470 | Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells. |
Q36291423 | Melatonin: an underappreciated player in retinal physiology and pathophysiology |
Q38190064 | New therapeutic targets for intraocular pressure lowering. |
Q38031910 | Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential |
Q41992739 | Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse. |
Q88040597 | Seasonal Reproduction in Vertebrates: Melatonin Synthesis, Binding, and Functionality Using Tinbergen's Four Questions |
Q37165143 | Seasonal changes of 24-hour intraocular pressure rhythm in healthy Shanghai population |
Q34601286 | Serotonin levels in aqueous humor of patients with primary open-angle glaucoma |
Q38709300 | TRPV4 Stimulation Induced Melatonin Secretion by Increasing Arylalkymine N-acetyltransferase (AANAT) Protein Level |
Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
Q37137215 | The effects of melatonin on anxiety and pain scores of patients, intraocular pressure, and operating conditions during cataract surgery under topical anesthesia. |
Q39402838 | The role and therapeutic potential of melatonin in age-related ocular diseases. |
Q36965736 | The role of melatonin in anaesthesia and critical care |
Q37809108 | The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential |
Q28266443 | Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy |
Search more.